Kala Azar in South Asia (Registro nro. 226496)

MARC details
000 -LIDER
fixed length control field 05552nam a22005295i 4500
001 - CONTROL NUMBER
control field 978-3-319-47101-3
003 - CONTROL NUMBER IDENTIFIER
control field DE-He213
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20180206183025.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 170112s2016 gw | s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9783319471013
-- 978-3-319-47101-3
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number QR251-255
072 #7 - SUBJECT CATEGORY CODE
Subject category code MMFP
Source bicssc
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED103000
Source bisacsh
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.96
Edition number 23
245 10 - TITLE STATEMENT
Title Kala Azar in South Asia
Medium [recurso electrónico] :
Remainder of title Current Status and Sustainable Challenges /
Statement of responsibility, etc. edited by E. Noiri, T.K. Jha.
250 ## - EDITION STATEMENT
Edition statement 2nd ed. 2016.
264 #1 -
-- Cham :
-- Springer International Publishing :
-- Imprint: Springer,
-- 2016.
300 ## - PHYSICAL DESCRIPTION
Extent XX, 309 p. 85 illus., 54 illus. in color.
Other physical details online resource.
336 ## -
-- text
-- txt
-- rdacontent
337 ## -
-- computer
-- c
-- rdamedia
338 ## -
-- online resource
-- cr
-- rdacarrier
347 ## -
-- text file
-- PDF
-- rda
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Preface. Part I Introduction into Kala-Azar Pathology and Mechanism of Disease in Kala-Azar -- Treatment of Post-kala-azar Dermal Leishmaniasis -- Characteristics of Patients Visiting Suruya Kanta Kala-Azar Research Center in Mymensingh, Bangladesh; Data from a Patient Registry System -- Epidemiology of Drug-Resistant Kala-Azar in India and Neighboring Countries -- Part II Therapeutic Strategy to Deal with Emergence of Drug Resistance -- A Therapeutic Strategy for Treating Visceral Leishmaniasis in Regions with Drug Resistance -- Treatment of Post-kala-azar Dermal Leishmaniasis -- Combination Therapy for Leishmaniasis -- Vaccine Development for Leishmaniasis -- Siccanin is a novel selective inhibitor of trypanosomatid complex II (succinate-ubiquinone reductase) and a potent broad-spectrum anti-trypanosomatid drug candidate -- Challenges in the Diagnosis of Visceral Leishmaniasis on the Indian Subcontinent -- Part III Diagnostic Strategy Enhancing Kala-Azar Elimination Program -- Changes of Leishmania antigens in kala-azar patients? urine after treatment -- Potentiality of Urinary L-FABP Tests to Kala-azar Disease Management -- Antibody Capture Direct Agglutination Test (abcDAT) for Diagnosis of Visceral Leishmaniasis with Urine -- Loop-mediated Isothermal Amplification (LAMP): Molecular Diagnosis for the Field Survey of Visceral Leishmaniasis -- Applicability of Multiplex Real-Time PCR to Visceral Leishmaniasis -- Immunoglobulins in the Pathophysiology of Visceral Leishmaniasis -- Part V Knowledge and Practice for Vector Control in Kala-Azar -- Geographical Distribution and Ecological Aspect of Sand Fly Species in Bangladesh -- The efficacy of long lasting insecticidal nets for leishmaniasis in Asia -- Environmental change and kala-azar with particular reference to Bangladesh -- Part VI. New Challenges in the Kala-azar Elimination Programme -- Drug Safety Monitoring for Liposomal Amphotericin B -- Resolution Mapping of Kala-azar Hot Spots Using GPS Logger and Urinary Antibody Measurements -- Geography and Reality of Kala-azar Endemic in Bangladesh, Analysis Using GIS and Urine-based Mass Screening -- Animal Models of Visceral Leishmaniasis and Applicability to Disease Control -- Pharmacovigilance on Therapeutic Protocols for Visceral Leishmaniasis. Index.
520 ## - SUMMARY, ETC.
Summary, etc. Visceral leishmaniasis (VL), (also known as black fever or Kala-azar) is a life-threatening disease first reported from the Indian subcontinent. VL ranks as the world?s second largest parasitic disease killer and is a neglected tropical disease. Most of those infected by this life-threatening disease are uneducated daily wagers working to support their families, and vectors easily disseminate the disease to their neighbors. Owing to recent involvement of stakeholders, the number of patients is decreasing, but eradication remains a distant goal. This second edition presents latest reports of visceral Leishmaniasis by specialists working at the forefront of the endemic areas in Indian subcontinent. It also introduces vaccine development and inhibitors to Trypanosomatidae; some of them describing feasibility studies in visceral Leishmaniasis for the first time. Recent progress of the Science and Technology Research Partnership for Sustainable Development (SATREPS) is also reviewed and the contents share this collaborative research from the forefront of endemic sites in Bangladesh. Widely covering basic, clinical, epidemiological and entomological aspects, this volume will be of great interest to dedicated researchers interested in Leishmaniasis and to experts of NTDs in global health. There is a tide in the affairs of men. Which, taken at the flood, leads on to fortune; Omitted, all the voyage of disease control is bound in shallows and in miseries. ~modified from Shakespeare ~.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Término temático o nombre geográfico como elemento de entrada Medicine.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Término temático o nombre geográfico como elemento de entrada Laboratory medicine.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Término temático o nombre geográfico como elemento de entrada Drug resistance.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Término temático o nombre geográfico como elemento de entrada Parasitology.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Término temático o nombre geográfico como elemento de entrada Nephrology.
650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM
Término temático o nombre geográfico como elemento de entrada Biomedicine.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Término temático o nombre geográfico como elemento de entrada Parasitology.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Término temático o nombre geográfico como elemento de entrada Drug Resistance.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Término temático o nombre geográfico como elemento de entrada Veterinary Medicine/Veterinary Science.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Término temático o nombre geográfico como elemento de entrada Laboratory Medicine.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Término temático o nombre geográfico como elemento de entrada Nephrology.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Noiri, E.
Relator term editor.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Jha, T.K.
Relator term editor.
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
773 0# - HOST ITEM ENTRY
Title Springer eBooks
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Printed edition:
International Standard Book Number 9783319436111
856 40 - ELECTRONIC LOCATION AND ACCESS
Public note Libro electrónico
Uniform Resource Identifier http://148.231.10.114:2048/login?url=http://dx.doi.org/10.1007/978-3-319-47101-3
912 ## -
-- ZDB-2-SBL
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Libro Electrónico
Existencias
Estado de retiro Colección Ubicación permanente Ubicación actual Fecha de ingreso Total Checkouts Date last seen Número de copia Tipo de material
  Colección de Libros Electrónicos Biblioteca Electrónica Biblioteca Electrónica 06/02/2018   06/02/2018 1 Libro Electrónico

Con tecnología Koha